Showing 1 - 3 results of 3 for search 'Chiun‐Sheng Huang' Skip to content
    • About the Library
    • Rules and Regulations
    • Library Services
    • Library Hours
  • Library News
    • Digital Repository
    • Google Scholar
    • ResearchGate
    • AJoGPL
    • KURJ
    • AJLS
    • MyLOFT
    • Lexis Plus UK
    • Britannica Academic
    • Research Support Tools
    • Quick Resource Links
  • Login
Advanced
  • Author
  • Chiun‐Sheng Huang
Showing 1 - 3 results of 3 for search 'Chiun‐Sheng Huang', query time: 0.01s Refine Results
  1. 1
    Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Analysis from EVEREXES Taiwan Subset

    Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Adv... by Yuan-Ching Chang, Kun-Ming Rau, Dar-Ren Chen, Tsu-Yi Chao, Ming-Feng Hou, Chiun-Sheng Huang*

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis

    Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐... by Ming‐Han Yang, Chiun‐Sheng Huang, Dwan‐Ying Chang, Fu‐Chang Hu, Shu‐Min Huang, Po‐Hsiang Huang, I‐Chun Chen, Tom Wei‐Wu Chen, Ching‐Hung Lin, Yen‐Shen Lu

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study

    Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study by Sung-Bae Kim, Hope S Rugo, Sara A Hurvitz, Hong-Tai Chang, Chiun-Sheng Huang, Su-Hua Lee, Jung-Tung Hung, Shir-Hwa Ueng, Shin-Cheh Chen, Alice L Yu, Ling-Ming Tseng, Louis W C Chow, Ming-Feng Hou, Richard B Schwab, James L Murray, Hsien-Kun Chang, Chwen-Cheng Chen

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs